Water splash
Sorbsan Silver Flat

Sorbsan Silver Flat is a sterile, non-woven, calcium alginate wound dressing, impregnated with silver, high in Mannuronic acid and low in Guluronic acid.

 

The fibres of Sorbsan Silver Flat swell and form Sodium-Calcium alginate gel in contact with wound exudate. The gel:

  • Provides a moist wound healing environment1
  • Conforms to the contours of the wound2,3
  • Atraumatic dressing removal3
  • Promotes haemostasis4,5
  • Minimises disruption to newly formed tissue6
Sorbsan Silver are broad spectrum antimicrobial dressings, effective against MRSA, VRE and MRSE7,8,9. The average silver content is 1.5%.
 
Wound types:
 
Application Sorbsan AG Flat
Sorbsan Silver Flat alginate wound dressing

INDICATIONS FOR USE

Sorbsan Silver Flat is intended for use of breached dermis, where the wounds can heal only by secondary intention:

  • Flat or shallow wounds
  • Infected wounds (when moderated heavily)

And is therefore suitable for the management of:

  • Partial and full thickness wounds
  • Arterial, venous and diabetic leg ulcers
  • Pressure ulcers
  • Post-operative wounds
  • Fungating lesions
  • Following toe-nail avulsions
  • Donor and graft sites
  • Traumatic wounds

CONTRA-INDICATIONS

Do not use on patients with a known sensitivity to silver or calcium alginate dressings.

Sorbsan Silver Flat should not be used in conjunction with topical medicine.

Sorbsan Silver Flat should not be used with heavily bleeding wounds.

Sorbsan Silver Flat should not be used as a surgical swab.

Always refer to the IFU provided with the dressing before use.

Download IFU

Application

Sorbsan Application
Sorbsan Application
Sorbsan Application
Sorbsan application
Sorbsan application

Ordering Information

Product codeDressingSizeQtyPiP codeNHS code
AG1400Sorbsan Silver Flat5cm x 5cm10327-0824tbc
AG1410Sorbsan Silver Flat10cm x 10cm10327-0816tbc
AG1415Sorbsan Silver Flat10cm x 20cm5327-0808tbc
Contact us

References

1. Clayton, C. An evaluation of Sorbsan Silver for use as an antimicrobial wound dressing. Proceedings of Wounds UK, Harrogate 2009

2. White R, Cutting K. Exploring the effects of Silver in Wound Management-What is Optimal? Wounds. 2006;18 (110: 307-314)

3. Thomas, S Alginates Update on Alginates. Journal of Woundcare May/June Vol.1. No.1 1992

4. Duward,R. Dr. and Clark, M Prof. Novel methods for measuring the ability of wound dressings to contribute to blood coagulation. Poster and presentation EWMA 2012

5. Gove, J. A multicentre study examining the role of calcium alginate dressing in bleeding and chronic wounds Poster presented at EPUAP,EWMA 2012

6. Gilchrist T, Martin AM (1983) Wound treatment with Sorbsan – an alginate fibre dressing. Biomaterials 4(4): 317–20

7. Hedger, C. Can patients who are enrolled into a multicentre study demonstrate improved clinical outcomes and cost effciency savings? Poster Wounds UK 2012

8. Little, ML. , Barnsholt T. Effects of a Silver Dressing on an in vitro pseudomonas aeruginosa biofilm EWMA Poster 2011

9. Hampton, S . A clinical evaluation of Sorbsan Silver in wounds colonised with Pseudomonas Au EWMA presentation and poster 2012